By late February 2021, a group of experts called Brighton Collaboration released a paper, which was published in Vaccine, clearly defining Vaccine-Associated Enhanced Disease (VAED), which is a more severe clinical presentation of a disease in a person vaccinated against that disease than would normally be seen in an unvaccinated person. Yet, Pfizer, public health, and media […]
Report 90: Pfizer’s ‘Post-Marketing Surveillance’ Shows mRNA-Vaccinated Suffered 1000s of COVID Cases in 1st 90 Days of Vaccine Rollout. Most Infections in the Vaccinated Categorized as ‘Serious Adverse Events.’
Though spokespeople assured us that the COVID-19 injection stops — well — COVID, Pfizer and the Food and Drug Administration (FDA) both knew that during the first three months of Pfizer’s mRNA COVID-19 vaccine rollout, thousands of COVID cases were reported to Pfizer — among vaccinated people. The ‘COVID-19 Adverse Events of Special Interest’ (AESI) […]
FOIA’d CDC Emails Reveal Disturbing Myocarditis Timeline Warranting Investigation: Different Messaging Internally Vs. Publicly About COVID-19 Vaccines and Myocarditis.
“We don’t have any evidence to suggest a signal or a safety problem for myocarditis[.]” Dr. Tom Shimabukuro, CDC, April 19, 2021 Investigative work by two intrepid scientists, combined with Freedom of Information Act (FOIA) records, reveal a disturbing chronology during which the Centers for Disease Control and Prevention (CDC) “delayed reporting the incidence […]
Report 78: Thirty-Two Percent of Pfizer’s Post-Marketing Respiratory Adverse Event Patients Died, Yet Pfizer Found No New Safety Signals.
The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Joseph Gehrett, MD; Barbara Gehrett, MD; Chris Flowers, MD; and Loree Britt – wrote a compelling analysis of Respiratory Adverse Events of Special Interest (AESIs) found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021 (a.k.a., […]
Report 77: Women Suffered 94% of Dermatological Adverse Events Reported in First 90 Days of Pfizer COVID “Vaccine” Rollout. 80% of These Adverse Events Were Categorized As “Serious.”
The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt – produced a report about Dermatological Adverse Events of Special Interest (AESIs) found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021 (a.k.a., “5.3.6“). […]
Report 72: “Other AESIs” Included MERS, Multiple Organ Dysfunction Syndrome (MODS), Herpes Infections, and 96 DEATHS. 15 Patients Were Under Age 12, Including Six Infants.
The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Joseph Gehrett, MD; Barbara Gehrett, MD; Chris Flowers, MD; and Loree Britt – wrote a report about Other Adverse Events of Special Interest (AESIs) found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021 (a.k.a., “5.3.6“). […]
Report 71: Musculoskeletal Adverse Events of Special Interest Afflicted 8.5% of Patients in Pfizer’s Post-Marketing Data Set, Including Four Children and One Infant. Women Affected at a Ratio of Almost 4:1 Over Men.
The War Room/DailyClout Pfizer Documents Analysis Project Post-Marketing Group (Team 1) – Barbara Gehrett, MD; Joseph Gehrett, MD; Chris Flowers, MD; and Loree Britt – wrote a review of musculoskeletal adverse events of special interest (AESIs) found in Pfizer document 5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-FEB-2021 (a.k.a., “5.3.6“). […]